Skip to main content

Animations

MJFF Publications

4111 - 4120 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2023
  • 2023
  • 2023
  • 2023
  • 2021
  • 2023
  • 2024
  • Summary Details
    OPEN
    Title: Exploring the role of underrepresented populations in polygenic risk scores for neurodegenerative disease risk prediction
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2024.1380860
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Impulse control disorders and use of dopamine agonists in early onset Parkinson’s disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1404904
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Deep Learning–based Approach for Brainstem and Ventricular MR Planimetry: Application in Patients with Progressive Supranuclear Palsy
    Journal Name: Radiology: Artificial Intelligence
    Publisher: Radiological Society of North America (RSNA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1148/ryai.230151
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Basal activity of PINK1 and PRKN in cell models and rodent brain
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2023.2286414
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients – Validation in the BioFIND cohort
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105765
    Citation Count: 2
  • Summary Details
    OPEN
    Title: An individualized tractography pipeline for the nucleus basalis of Meynert lateral tract
    Journal Name: Imaging Neuroscience
    Publisher: MIT Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1162/imag_a_00067
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcad346
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Assessing the relationship between monoallelic PRKN mutations and Parkinson’s risk
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddaa273
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology
    Journal Name: Clinical Chemistry
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/clinchem/hvad139
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae055
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.